News Sentiment

CDIO sentiment intelligence

Cardio Diagnostics Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.72 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-6.0% over one week, -13.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

What's Driving Cardio Diagnostics Holdings' Recent Stock Surge

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -6.0% Price reacting lower
Trend fit Trend inactive -13.1% over four weeks
Fair value -89.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 30
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Market source 9
Stock Titan 8
NewMediaWire 6
timothysykes.com 3
Barchart.com 2
Business Wire 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 11
Deals and strategy 3
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 49
TradingView Direct company coverage

Price to book forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW

This article provides the "Price to book forward" for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIOW) and highlights that the market was closed with no trades. It also mentions that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr.

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 04:41
Source
TradingView
Stock Titan Direct company coverage

Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M

Cardio Diagnostics Holdings, Inc. (CDIO) is seeking shareholder approval for a 2026 Issuance Proposal to issue up to 5.0 million shares of common stock, or equivalents, for up to $10.0 million in non-public financings. This proposal aims to provide the company with an alternative

Tone
Negative 38/100
Event
Regulatory and legal
Published
13 Jul 2026 20:40
Source
Stock Titan
TradingView Direct company coverage

Price to earnings forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW

The article provides a financial snapshot for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIOW), specifically focusing on its forward price-to-earnings ratio. It emphasizes that this data is subject to various market data and reference data providers. The page itself serves as a d

Tone
Neutral 50/100
Event
Earnings
Published
13 Jul 2026 15:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIOW

The article discusses the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc., traded on NASDAQ under the symbol CDIOW. It appears to be a financial data page from TradingView, focusing on key financial metrics for the company. The content primarily lists and li

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 01:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO

This article provides financial information for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), specifically displaying its enterprise value to revenue (forward) data. The content is presented within the TradingView platform's market data interface, focusing on key financial metr

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 11:13
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO

This article provides a brief financial overview for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or an introductory page from TradingView, indicating where users might find this fi

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 12:13
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO

This article provides the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) as displayed on TradingView. It indicates that the market was closed with no trades at the time of publication and offers various navigational options within the TradingV

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO

This article presents financial data, specifically the "Price to sales forward," for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO). It is presented within a TradingView context, indicating stock market data and financial analysis. The content is primarily a data point for the s

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 11:10
Source
TradingView
TradingView Direct company coverage

Price to book forward of Cardio Diagnostics Holdings Inc. – NASDAQ:CDIO

This article displays the "Price to book forward" financial metric for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) on TradingView. It appears to be a stub or a section of a larger financial data display, indicating no specific value or change in the metric at the time of publ

Tone
Neutral 50/100
Event
Market update
Published
03 Jul 2026 06:10
Source
TradingView
Stock Titan Direct company coverage

Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price

Cardio Diagnostics Holdings director James Intrater was granted 2,854 stock options at a strike price of $2.19 per share, expiring on June 30, 2036. This grant increases his total direct holdings to options for 13,318 shares. The transaction was reported on July 2, 2026, and is p

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 23:10
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com

This article reports on a Form 4 filing for Cardio Diagnostics Holdings Inc. on July 2. It appears to be a standard financial news brief announcing the availability of SEC filing information for the company. The content also briefly mentions the company's stock symbol, CDIO, alon

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 16:40
Source
Investing.com Canada
Stock Titan Direct company coverage

Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike

Peter K. Fung, a director at Cardio Diagnostics Holdings, Inc. (CDIO), was granted 2,854 stock options on June 30, 2026, with an exercise price of $2.19 per share. These options are part of his compensation, granting him the right to purchase shares, and will expire in 2036. Foll

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 16:40
Source
Stock Titan
Stock Titan Direct company coverage

Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19

Cardio Diagnostics Holdings director Burton Paul Frederick was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This award is part of his equity-based compensation and increases his direct holdings to 13,318 stock options. The Form

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 16:40
Source
Stock Titan
Stock Titan Direct company coverage

Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19

Cardio Diagnostics Holdings, Inc. director Wendy J. Betts was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This compensation-related award increases her directly held stock options to a total of 12,367 underlying shares. The tr

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 16:40
Source
Stock Titan
NewMediaWire Direct company coverage

Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans

Cardio Diagnostics Holdings (CDIO), a precision cardiovascular medicine company, has highlighted its innovative approaches to cardiovascular disease prevention and risk assessment at recent national benefits conferences. The company emphasizes that earlier identification of cardi

Tone
Positive 70/100
Event
Market update
Published
01 Jul 2026 18:10
Source
NewMediaWire
Market source Direct company coverage

Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

Cardio Diagnostics Holdings (CDIO) is utilizing epigenetics to identify hidden heart disease risks, moving beyond traditional genetic assessments. The company emphasizes that epigenetics, which studies how gene expression is regulated without altering the DNA sequence, offers val

Tone
Positive 71/100
Event
Market update
Published
30 Jun 2026 18:42
Source
Market source
The Globe and Mail Direct company coverage

Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans

Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision cardiovascular medicine company, recently presented its innovative solutions for cardiovascular disease prevention, risk assessment, and cost management at national benefits conferences. The company emphasizes early identifi

Tone
Positive 77/100
Event
Market update
Published
30 Jun 2026 02:40
Source
The Globe and Mail
TradingView Direct company coverage

Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO)

This article provides current and historical financial data for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), including its stock price, market capitalization, volatility, and net income. It also addresses frequently asked questions about the company's stock performance, future

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 09:09
Source
TradingView
Barchart.com Direct company coverage

Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians

Cardio Diagnostics Holdings announced that Atlas Healthcare Physicians will now cover its Epi+Gen CHD(TM) and PrecisionCHD(TM) tests. This expansion will provide eligible members in Los Angeles and Orange counties with access to these noninvasive, AI-powered precision cardiovascu

Tone
Positive 71/100
Event
Market update
Published
25 Jun 2026 09:10
Source
Barchart.com
Stock Titan Direct company coverage

Atlas Healthcare will cover Cardio Diagnostics heart tests for members

Cardio Diagnostics Holdings, Inc. announced that Atlas Healthcare Physicians (AHP) will cover its precision cardiovascular medicine tests, Epi+Gen CHD™ and PrecisionCHD™, for members in Southern California starting May 2026. This partnership aims to improve early detection, perso

Tone
Positive 72/100
Event
Deals and strategy
Published
24 Jun 2026 19:11
Source
Stock Titan
Business Wire Direct company coverage

Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network

Atlas Healthcare Physicians (AHP), an independent physician association in Southern California, will begin covering Cardio Diagnostics’ precision cardiovascular medicine tests, Epi+Gen CHD™ and PrecisionCHD™, for its members in May 2026. This partnership aims to provide physician

Tone
Positive 73/100
Event
Deals and strategy
Published
24 Jun 2026 12:09
Source
Business Wire
Moomoo Direct company coverage

Cardio Diagnostics Company Profile & Introduction

This article provides a company profile and introduction to Cardio Diagnostics. Additional details about the company, likely including its operations, mission, and services, would be included in the full document.

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 11:10
Source
Moomoo
Market source Direct company coverage

Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI

Cardio Diagnostics Holdings (CDIO) is addressing the persistent and costly problem of heart disease, the leading cause of death in the US, using an innovative approach combining AI, epigenetics, and genetics. The company aims to detect coronary heart disease earlier and more sens

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 18:41
Source
Market source
TradingView Direct company coverage

Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI

Cardio Diagnostics Holdings (NASDAQ: CDIO) is addressing the significant and growing problem of heart disease, forecasted to incur $1.4 trillion in healthcare costs by 2050, by leveraging epigenetics and AI for early and accurate detection of coronary heart disease. The company's

Tone
Positive 90/100
Event
Market update
Published
23 Jun 2026 17:41
Source
TradingView